From: Total Exposure Study Analysis consortium: a cross-sectional study of tobacco exposures
 | β | SE | t | P | FMIa |
---|---|---|---|---|---|
Sex | 0.191 | 0.123 | 1.550 | 0.121 | 0.009 |
BMIb | 0.015 | 0.008 | 1.860 | 0.063 | 0.010 |
Self-identified race | −0.598 | 0.125 | −4.780 | 0.000 | 0.006 |
Education (HS/some College) | 0.001 | 0.146 | 0.010 | 0.993 | 0.011 |
Education (≥Bachelors) | −0.129 | 0.173 | −0.740 | 0.457 | 0.010 |
Age | 0.057 | 0.020 | 2.800 | 0.005 | 0.003 |
Age squared | −0.001 | 0.000 | −2.930 | 0.003 | 0.003 |
Smoking duration | 0.007 | 0.006 | 1.280 | 0.201 | 0.031 |
11–20 CPD | 0.101 | 0.114 | 0.890 | 0.374 | 0.009 |
21–30 CPD | 0.143 | 0.162 | 0.880 | 0.379 | 0.010 |
>30 CPD | 0.215 | 0.243 | 0.880 | 0.377 | 0.020 |
CPDb | 0.001 | 0.009 | 0.070 | 0.944 | 0.011 |
FTC tar | −0.002 | 0.008 | −0.300 | 0.767 | 0.004 |
Nicotine equivalents/cigarette | −0.085 | 0.162 | −0.530 | 0.599 | 0.042 |
Nicotine equivalents/24Â h | 0.034 | 0.015 | 2.350 | 0.019 | 0.028 |
Serum cotinine | −0.001 | 0.001 | −2.070 | 0.038 | 0.027 |
Total NNAL/cigarette | 0.006 | 0.005 | 1.220 | 0.224 | 0.034 |
Total NNAL/24 h | 0.000 | 0.000 | −0.190 | 0.849 | 0.025 |
Carboxyhemoglobin | −0.019 | 0.027 | −0.700 | 0.486 | 0.007 |
1-OHP | 0.000 | 0.000 | 0.000 | 0.999 | 0.005 |
3-HPMA | 0.000 | 0.000 | 0.010 | 0.990 | 0.010 |
4-ABP | 0.001 | 0.001 | 0.840 | 0.400 | 0.317 |
MHBMA | −0.030 | 0.015 | −1.980 | 0.048 | 0.069 |
DHBMA | 0.000 | 0.000 | −0.820 | 0.410 | 0.006 |
8-epi-prostaglandin-F2αb | 0.000 | 0.000 | −0.630 | 0.527 | 0.010 |
Total bilirubin | −0.147 | 0.177 | −0.830 | 0.406 | 0.051 |
Hematocrit | 0.018 | 0.026 | 0.680 | 0.495 | 0.027 |
Hemoglobin | −0.071 | 0.077 | −0.930 | 0.351 | 0.024 |
Platelets | −0.001 | 0.001 | −1.280 | 0.200 | 0.051 |
WBC | −0.007 | 0.020 | −0.370 | 0.715 | 0.026 |
Microalbumin | 0.000 | 0.000 | 0.960 | 0.341 | 0.409 |
11-dehydrothromboxane-B2 | 0.000 | 0.000 | 0.720 | 0.472 | 0.108 |
hs-CRP | 0.007 | 0.007 | 1.020 | 0.306 | 0.072 |
Fibrinogen | 0.000 | 0.001 | 0.560 | 0.575 | 0.052 |
von Willebrand factor | 0.000 | 0.001 | 0.260 | 0.798 | 0.019 |
Serum creatinine | 0.220 | 0.259 | 0.850 | 0.396 | 0.021 |
Blood urea nitrogen | −0.004 | 0.011 | −0.360 | 0.720 | 0.005 |
Total cholesterol | 0.021 | 0.138 | 0.160 | 0.877 | 0.030 |
HDL | −0.019 | 0.138 | −0.140 | 0.890 | 0.030 |
LDL | −0.022 | 0.138 | −0.160 | 0.872 | 0.030 |
Triglycerides | −0.004 | 0.028 | −0.150 | 0.882 | 0.031 |
Alkaline phosphatase | −0.001 | 0.002 | −0.840 | 0.401 | 0.009 |
Alanine aminotransferase | 0.001 | 0.003 | 0.380 | 0.700 | 0.012 |
Aspartate aminotransferase | −0.006 | 0.004 | −1.580 | 0.113 | 0.022 |
Lactate dehydrogenase | 0.003 | 0.001 | 1.880 | 0.060 | 0.041 |
FEV1 excluding extreme valuesb | −0.003 | 0.003 | −0.930 | 0.352 | 0.002 |
FVC excluding extreme valuesb | 0.010 | 0.003 | 4.030 | 0.000 | 0.003 |
Serum albumin | 0.178 | 0.141 | 1.260 | 0.206 | 0.022 |
Serum glucose | −0.003 | 0.001 | −1.850 | 0.065 | 0.019 |
Uric acid | −0.027 | 0.037 | −0.730 | 0.464 | 0.004 |
Diastolic BP, Visit 1 | 0.005 | 0.006 | 0.830 | 0.405 | 0.003 |
Diastolic BP, Visit 2 | −0.005 | 0.006 | −0.760 | 0.446 | 0.002 |
Systolic BP, Visit 1 | 0.000 | 0.004 | 0.100 | 0.919 | 0.003 |
Systolic BP, Visit 2 | 0.003 | 0.004 | 0.680 | 0.498 | 0.002 |
Heart rate, Visit 1 | −0.007 | 0.005 | −1.500 | 0.134 | 0.003 |
Heart rate, Visit 2 | 0.003 | 0.005 | 0.580 | 0.563 | 0.003 |
Constant | −2.243 | 0.988 | −2.270 | 0.023 | 0.006 |